# Management of Treatment‐Resistant Dermatitis Herpetiformis With Tofacitinib: A Case Report

## TL;DR

Tofacitinib successfully treated a patient with severe dermatitis herpetiformis who did not respond to standard treatments.

## Contribution

This case report demonstrates tofacitinib's potential as a treatment for treatment-resistant dermatitis herpetiformis.

## Key findings

- Tofacitinib provided effective treatment for dermatitis herpetiformis unresponsive to dapsone and gluten-free diet.
- JAK inhibition may be beneficial for refractory autoimmune skin diseases.

## Abstract

Tofacitinib may offer a safe and effective treatment alternative for patients with dermatitis herpetiformis unresponsive to dapsone and a gluten‐free diet, highlighting the potential role of JAK inhibition in refractory autoimmune skin diseases.